| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.114 | 13.009 | 14.319 | 20.577 | 0 | 1.422 | 20.721 | 25.651 | 24.346 |
| Total Income - EUR | - | 7.114 | 13.009 | 14.319 | 20.577 | 0 | 1.422 | 20.721 | 25.651 | 24.346 |
| Total Expenses - EUR | - | 1.370 | 1.952 | 1.423 | 3.385 | 5.363 | 5.070 | 6.696 | 15.577 | 13.935 |
| Gross Profit/Loss - EUR | - | 5.745 | 11.057 | 12.895 | 17.192 | -5.363 | -3.647 | 14.026 | 10.073 | 10.411 |
| Net Profit/Loss - EUR | - | 5.531 | 10.666 | 12.466 | 16.575 | -5.363 | -3.689 | 13.511 | 9.822 | 9.695 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ralucalife Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 75 | 18 | 0 | 13.127 | 9.519 | 6.982 | 3.601 | 2.928 | 3.507 |
| Current Assets | - | 5.870 | 10.788 | 12.763 | 5.393 | 3.199 | 4.282 | 10.794 | 7.360 | 7.265 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 604 | 869 | 1.302 | 889 | 0 | 1.422 | 1.620 | 2.241 | 335 |
| Cash | - | 5.266 | 9.919 | 11.461 | 4.504 | 3.199 | 2.860 | 9.174 | 5.118 | 6.931 |
| Shareholders Funds | - | 5.576 | 10.710 | 12.509 | 16.617 | 10.939 | 7.007 | 13.551 | 9.863 | 9.735 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 369 | 96 | 254 | 1.903 | 1.779 | 4.328 | 914 | 425 | 1.037 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ralucalife Med Srl